Analytical Data
-
Gene name
TAF13
- Application
-
Alternative Names
TAF2K; TAFII18; Transcription Initiation Factor TFIID Subunit 13; Transcription initiation factor TFIID 18 kDa subunit
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q15543
-
Expression Region
Met1~Ser124
-
Molecular Weight
20kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAF13, a subunit of the general transcription machinery, plays a critical role in the regulation of gene expression and is a component of the TFIID complex, which is essential for the initiation of transcription by RNA polymerase II. This protein has gained significant attention in recent years due to its involvement in various cellular processes, including transcriptional activation, cell differentiation, and response to stress. Studies have suggested that TAF13 may also have implications in oncogenesis and other diseases, making it a potential target for therapeutic interventions. The expression and functional analysis of recombinant TAF13 protein have been pivotal for understanding its structural and functional properties. Researchers utilize recombinant DNA technology to produce TAF13, allowing for detailed studies on its interactions with other transcription factors and co-regulators. Understanding the mechanisms by which TAF13 modulates transcription can provide insights into the complex regulatory networks that underlie gene expression and contribute to the development of diseases. As such, ongoing research into TAF13 and its recombinant forms aims to elucidate its role in biology and medicine, paving the way for novel approaches in disease treatment and gene therapy.
